

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 9.19357676 |
| 2 | cytidine catabolic process (GO:0006216) | 9.19357676 |
| 3 | cytidine deamination (GO:0009972) | 9.19357676 |
| 4 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 8.79499038 |
| 5 | DNA deamination (GO:0045006) | 8.37988184 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 8.19709811 |
| 7 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 5.51425069 |
| 8 | regulation of activation of Janus kinase activity (GO:0010533) | 5.15762899 |
| 9 | actin nucleation (GO:0045010) | 5.04968176 |
| 10 | positive T cell selection (GO:0043368) | 5.02594878 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.90238982 |
| 12 | cellular response to interleukin-15 (GO:0071350) | 4.84703085 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.84449264 |
| 14 | negative T cell selection (GO:0043383) | 4.67230060 |
| 15 | T cell migration (GO:0072678) | 4.63905414 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.60966298 |
| 17 | negative regulation of T cell apoptotic process (GO:0070233) | 4.49669640 |
| 18 | negative regulation by host of viral transcription (GO:0043922) | 4.42593794 |
| 19 | positive regulation of calcium-mediated signaling (GO:0050850) | 4.38154156 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.28004076 |
| 21 | sequestering of actin monomers (GO:0042989) | 4.23166435 |
| 22 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.22457300 |
| 23 | positive regulation of interleukin-8 secretion (GO:2000484) | 4.22107566 |
| 24 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.16750448 |
| 25 | eosinophil chemotaxis (GO:0048245) | 4.13918161 |
| 26 | cytolysis (GO:0019835) | 4.04929112 |
| 27 | pyrimidine nucleoside catabolic process (GO:0046135) | 4.04537125 |
| 28 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.03268269 |
| 29 | regulation of regulatory T cell differentiation (GO:0045589) | 4.01291248 |
| 30 | negative regulation of viral genome replication (GO:0045071) | 3.96270413 |
| 31 | regulation of T cell tolerance induction (GO:0002664) | 3.91694597 |
| 32 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.89487927 |
| 33 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.88967370 |
| 34 | positive regulation of tolerance induction (GO:0002645) | 3.86577774 |
| 35 | response to interleukin-15 (GO:0070672) | 3.77512568 |
| 36 | eosinophil migration (GO:0072677) | 3.76847879 |
| 37 | thymic T cell selection (GO:0045061) | 3.70886825 |
| 38 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.68541670 |
| 39 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.68219771 |
| 40 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.68219771 |
| 41 | T cell receptor signaling pathway (GO:0050852) | 3.67462103 |
| 42 | negative thymic T cell selection (GO:0045060) | 3.63191697 |
| 43 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.61471205 |
| 44 | regulation of chronic inflammatory response (GO:0002676) | 3.60724979 |
| 45 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.60323456 |
| 46 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.59604511 |
| 47 | positive regulation of T cell chemotaxis (GO:0010820) | 3.59096297 |
| 48 | regulation of T cell chemotaxis (GO:0010819) | 3.59096297 |
| 49 | macrophage chemotaxis (GO:0048246) | 3.56733510 |
| 50 | T cell selection (GO:0045058) | 3.56113414 |
| 51 | regulation of interleukin-8 secretion (GO:2000482) | 3.55146018 |
| 52 | T cell costimulation (GO:0031295) | 3.46640593 |
| 53 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45885477 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.42435758 |
| 55 | positive regulation of cell killing (GO:0031343) | 3.40694515 |
| 56 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.40221654 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.36306925 |
| 58 | interferon-gamma production (GO:0032609) | 3.35912660 |
| 59 | positive regulation of defense response to virus by host (GO:0002230) | 3.35861297 |
| 60 | regulation of tolerance induction (GO:0002643) | 3.32712616 |
| 61 | regulation of B cell differentiation (GO:0045577) | 3.29093350 |
| 62 | cellular defense response (GO:0006968) | 3.27307328 |
| 63 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.25299289 |
| 64 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 3.23852355 |
| 65 | regulation of cell killing (GO:0031341) | 3.21355602 |
| 66 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.21109409 |
| 67 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.20384394 |
| 68 | lymphocyte chemotaxis (GO:0048247) | 3.20259265 |
| 69 | regulation of calcium-mediated signaling (GO:0050848) | 3.18362829 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.17883806 |
| 71 | positive regulation of lymphocyte migration (GO:2000403) | 3.11562598 |
| 72 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.09344701 |
| 73 | positive regulation of B cell differentiation (GO:0045579) | 3.05804045 |
| 74 | regulation of T cell apoptotic process (GO:0070232) | 3.04433089 |
| 75 | positive regulation of interleukin-4 production (GO:0032753) | 3.01449354 |
| 76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.95072466 |
| 77 | regulation of viral genome replication (GO:0045069) | 2.94864505 |
| 78 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91113759 |
| 79 | monocyte chemotaxis (GO:0002548) | 2.89506271 |
| 80 | lymphocyte migration (GO:0072676) | 2.89398992 |
| 81 | dendritic cell chemotaxis (GO:0002407) | 2.88281188 |
| 82 | negative regulation of cell killing (GO:0031342) | 2.80906318 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.80906318 |
| 84 | ATP synthesis coupled proton transport (GO:0015986) | 2.80075202 |
| 85 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.80075202 |
| 86 | response to interferon-beta (GO:0035456) | 2.78558867 |
| 87 | mast cell activation (GO:0045576) | 2.78001781 |
| 88 | negative regulation of stress fiber assembly (GO:0051497) | 2.77190385 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75621471 |
| 90 | positive regulation of T cell apoptotic process (GO:0070234) | 2.75508761 |
| 91 | protein neddylation (GO:0045116) | 2.73825097 |
| 92 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.73076533 |
| 93 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.72870332 |
| 94 | positive regulation of tyrosine phosphorylation of Stat5 protein (GO:0042523) | 2.65167087 |
| 95 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.64316563 |
| 96 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.63664228 |
| 97 | immunoglobulin mediated immune response (GO:0016064) | 2.62809138 |
| 98 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.62741566 |
| 99 | chemokine-mediated signaling pathway (GO:0070098) | 2.62645049 |
| 100 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.58590206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.49570658 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.48167584 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.31320488 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.21080094 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.34285370 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.29437191 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.25060950 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.15079095 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.99271816 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.96123314 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.89350579 |
| 12 | MYB_26560356_Chip-Seq_TH2_Human | 2.65964020 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.41077710 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25579360 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23545806 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.23221011 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.08716374 |
| 18 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.06212548 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.94446631 |
| 20 | GATA3_26560356_Chip-Seq_TH2_Human | 1.80377442 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.80178936 |
| 22 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78825288 |
| 23 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.77984832 |
| 24 | MYB_26560356_Chip-Seq_TH1_Human | 1.75957109 |
| 25 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.71750107 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.71537855 |
| 27 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67491820 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.65517837 |
| 29 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.63788666 |
| 30 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.63250383 |
| 31 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.55881402 |
| 32 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45795402 |
| 33 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.44458820 |
| 34 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.43865853 |
| 35 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.41402420 |
| 36 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.37589088 |
| 37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33241616 |
| 38 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.33029476 |
| 39 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31032240 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28925053 |
| 41 | MAF_26560356_Chip-Seq_TH2_Human | 1.28108228 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.27204528 |
| 43 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.26549171 |
| 44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.24742415 |
| 45 | MAF_26560356_Chip-Seq_TH1_Human | 1.23730679 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23206450 |
| 47 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.19810795 |
| 48 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19396342 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19126697 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18356266 |
| 51 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.17979604 |
| 52 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16777528 |
| 53 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.16717468 |
| 54 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.16280877 |
| 55 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.15207884 |
| 56 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.14453710 |
| 57 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.11857432 |
| 58 | AR_20517297_ChIP-Seq_VCAP_Human | 1.10900939 |
| 59 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10749227 |
| 60 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.10479394 |
| 61 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10444847 |
| 62 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.07763424 |
| 63 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.06957336 |
| 64 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.03563582 |
| 65 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.03250532 |
| 66 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01978730 |
| 67 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.00066501 |
| 68 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.00066501 |
| 69 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99806964 |
| 70 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.99481517 |
| 71 | NCOR_22424771_ChIP-Seq_293T_Human | 0.97165297 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96541078 |
| 73 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96483953 |
| 74 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94693589 |
| 75 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94302250 |
| 76 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.93999011 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92008752 |
| 78 | P300_27268052_Chip-Seq_Bcells_Human | 0.91928536 |
| 79 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.91247826 |
| 80 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91156843 |
| 81 | GATA3_26560356_Chip-Seq_TH1_Human | 0.89745016 |
| 82 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89712272 |
| 83 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88792540 |
| 84 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88745300 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.88531285 |
| 86 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.88015376 |
| 87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87468771 |
| 88 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.85708530 |
| 89 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85095002 |
| 90 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.84965992 |
| 91 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.84503999 |
| 92 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.84111352 |
| 93 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.84111352 |
| 94 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83747085 |
| 95 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.82818488 |
| 96 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.82754934 |
| 97 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82700176 |
| 98 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.82571555 |
| 99 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.82215289 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.81595385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.71785149 |
| 2 | MP0009785_altered_susceptibility_to | 3.81979301 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.63261798 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.25155749 |
| 5 | MP0005000_abnormal_immune_tolerance | 3.02703959 |
| 6 | MP0001800_abnormal_humoral_immune | 2.67925969 |
| 7 | MP0009333_abnormal_splenocyte_physiolog | 2.60262589 |
| 8 | MP0002148_abnormal_hypersensitivity_rea | 2.56861233 |
| 9 | MP0002723_abnormal_immune_serum | 2.56052876 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.49757168 |
| 11 | MP0005025_abnormal_response_to | 2.48078736 |
| 12 | MP0003866_abnormal_defecation | 2.47730929 |
| 13 | MP0000685_abnormal_immune_system | 2.44784037 |
| 14 | MP0001819_abnormal_immune_cell | 2.43871222 |
| 15 | MP0002166_altered_tumor_susceptibility | 2.43468529 |
| 16 | MP0005387_immune_system_phenotype | 2.32822750 |
| 17 | MP0001790_abnormal_immune_system | 2.32822750 |
| 18 | MP0006082_CNS_inflammation | 2.23167854 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.12306142 |
| 20 | MP0003436_decreased_susceptibility_to | 2.11002881 |
| 21 | MP0005645_abnormal_hypothalamus_physiol | 1.95777313 |
| 22 | MP0006072_abnormal_retinal_apoptosis | 1.88309780 |
| 23 | MP0002006_tumorigenesis | 1.86876342 |
| 24 | MP0003724_increased_susceptibility_to | 1.86072082 |
| 25 | MP0000716_abnormal_immune_system | 1.85432168 |
| 26 | MP0002398_abnormal_bone_marrow | 1.84714934 |
| 27 | MP0001873_stomach_inflammation | 1.82936227 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.75688045 |
| 29 | MP0002405_respiratory_system_inflammati | 1.73929572 |
| 30 | MP0002419_abnormal_innate_immunity | 1.71736556 |
| 31 | MP0002933_joint_inflammation | 1.66420233 |
| 32 | MP0000703_abnormal_thymus_morphology | 1.62246917 |
| 33 | MP0002722_abnormal_immune_system | 1.59140534 |
| 34 | MP0001845_abnormal_inflammatory_respons | 1.57174031 |
| 35 | MP0002102_abnormal_ear_morphology | 1.56606935 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.55715061 |
| 37 | MP0004145_abnormal_muscle_electrophysio | 1.46783153 |
| 38 | MP0003448_altered_tumor_morphology | 1.41260828 |
| 39 | MP0004947_skin_inflammation | 1.40747145 |
| 40 | MP0002429_abnormal_blood_cell | 1.39573211 |
| 41 | MP0003045_fibrosis | 1.38287322 |
| 42 | MP0001905_abnormal_dopamine_level | 1.33125435 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.32836268 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.29559743 |
| 45 | MP0001542_abnormal_bone_strength | 1.26923811 |
| 46 | MP0009764_decreased_sensitivity_to | 1.20882057 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.19166705 |
| 48 | MP0003646_muscle_fatigue | 1.18509249 |
| 49 | MP0008469_abnormal_protein_level | 1.18487250 |
| 50 | MP0003786_premature_aging | 1.17650172 |
| 51 | MP0005464_abnormal_platelet_physiology | 1.16362283 |
| 52 | MP0003011_delayed_dark_adaptation | 1.16203163 |
| 53 | MP0008995_early_reproductive_senescence | 1.08205001 |
| 54 | MP0004147_increased_porphyrin_level | 1.05256587 |
| 55 | MP0009763_increased_sensitivity_to | 1.04569389 |
| 56 | MP0002277_abnormal_respiratory_mucosa | 1.00978359 |
| 57 | MP0005075_abnormal_melanosome_morpholog | 1.00564856 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.00376865 |
| 59 | MP0008872_abnormal_physiological_respon | 0.98174541 |
| 60 | MP0001919_abnormal_reproductive_system | 0.97041440 |
| 61 | MP0001853_heart_inflammation | 0.96048691 |
| 62 | MP0005377_hearing/vestibular/ear_phenot | 0.95842908 |
| 63 | MP0003878_abnormal_ear_physiology | 0.95842908 |
| 64 | MP0002693_abnormal_pancreas_physiology | 0.92015220 |
| 65 | MP0003195_calcinosis | 0.91687642 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.91661558 |
| 67 | MP0005253_abnormal_eye_physiology | 0.91434017 |
| 68 | MP0005551_abnormal_eye_electrophysiolog | 0.91097570 |
| 69 | MP0001968_abnormal_touch/_nociception | 0.90549820 |
| 70 | MP0002095_abnormal_skin_pigmentation | 0.87180006 |
| 71 | MP0005084_abnormal_gallbladder_morpholo | 0.86366664 |
| 72 | MP0003137_abnormal_impulse_conducting | 0.85912125 |
| 73 | MP0001501_abnormal_sleep_pattern | 0.83880527 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.79289255 |
| 75 | MP0004381_abnormal_hair_follicle | 0.78078494 |
| 76 | MP0005166_decreased_susceptibility_to | 0.76659662 |
| 77 | MP0003075_altered_response_to | 0.76605930 |
| 78 | MP0000858_altered_metastatic_potential | 0.76375875 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.76225919 |
| 80 | MP0008875_abnormal_xenobiotic_pharmacok | 0.75688775 |
| 81 | MP0004142_abnormal_muscle_tone | 0.74649302 |
| 82 | MP0009379_abnormal_foot_pigmentation | 0.74236452 |
| 83 | MP0005389_reproductive_system_phenotype | 0.71730789 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.71565636 |
| 85 | MP0002019_abnormal_tumor_incidence | 0.70921633 |
| 86 | MP0001485_abnormal_pinna_reflex | 0.69900537 |
| 87 | MP0004885_abnormal_endolymph | 0.69044619 |
| 88 | MP0002736_abnormal_nociception_after | 0.68657520 |
| 89 | MP0002138_abnormal_hepatobiliary_system | 0.66086962 |
| 90 | MP0002163_abnormal_gland_morphology | 0.64409217 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.61817132 |
| 92 | MP0008873_increased_physiological_sensi | 0.61781766 |
| 93 | MP0002733_abnormal_thermal_nociception | 0.60795756 |
| 94 | MP0002234_abnormal_pharynx_morphology | 0.59141822 |
| 95 | MP0005390_skeleton_phenotype | 0.57355819 |
| 96 | MP0003880_abnormal_central_pattern | 0.57072313 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.56697372 |
| 98 | MP0001243_abnormal_dermal_layer | 0.55976163 |
| 99 | MP0001661_extended_life_span | 0.55692895 |
| 100 | MP0004742_abnormal_vestibular_system | 0.55211047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.19773599 |
| 2 | Abnormality of T cell number (HP:0011839) | 5.82429288 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.62932732 |
| 4 | Aplastic anemia (HP:0001915) | 5.19542218 |
| 5 | IgG deficiency (HP:0004315) | 5.17110465 |
| 6 | Severe combined immunodeficiency (HP:0004430) | 4.71731297 |
| 7 | Hypoproteinemia (HP:0003075) | 4.26515502 |
| 8 | Abnormality of T cells (HP:0002843) | 3.98836624 |
| 9 | Increased IgM level (HP:0003496) | 3.80550416 |
| 10 | Autoimmune hemolytic anemia (HP:0001890) | 3.69062545 |
| 11 | Combined immunodeficiency (HP:0005387) | 3.67977353 |
| 12 | Thyroiditis (HP:0100646) | 3.51222454 |
| 13 | Abnormality of eosinophils (HP:0001879) | 3.49552481 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.36668776 |
| 15 | Abnormality of B cell number (HP:0010975) | 3.30968037 |
| 16 | Abnormality of the prostate (HP:0008775) | 3.30687141 |
| 17 | Stomatitis (HP:0010280) | 3.28475058 |
| 18 | Chronic diarrhea (HP:0002028) | 3.20038249 |
| 19 | Mitochondrial inheritance (HP:0001427) | 3.06722530 |
| 20 | Eosinophilia (HP:0001880) | 2.92875333 |
| 21 | B lymphocytopenia (HP:0010976) | 2.87066846 |
| 22 | 3-Methylglutaconic aciduria (HP:0003535) | 2.83915023 |
| 23 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.78319992 |
| 24 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.78319992 |
| 25 | Hepatocellular necrosis (HP:0001404) | 2.76772615 |
| 26 | Leukocytosis (HP:0001974) | 2.74200468 |
| 27 | Encephalitis (HP:0002383) | 2.68595101 |
| 28 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.67834108 |
| 29 | IgM deficiency (HP:0002850) | 2.64817950 |
| 30 | Myositis (HP:0100614) | 2.64404374 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.62734040 |
| 32 | Hepatic necrosis (HP:0002605) | 2.55984522 |
| 33 | Increased CSF lactate (HP:0002490) | 2.55723660 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 2.55419534 |
| 35 | Meningitis (HP:0001287) | 2.54091098 |
| 36 | Recurrent bronchitis (HP:0002837) | 2.52795097 |
| 37 | Methylmalonic acidemia (HP:0002912) | 2.49995459 |
| 38 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.49787406 |
| 39 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.49625659 |
| 40 | Amyotrophic lateral sclerosis (HP:0007354) | 2.46922823 |
| 41 | Abnormality of macrophages (HP:0004311) | 2.44977680 |
| 42 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44518354 |
| 43 | Renal cortical cysts (HP:0000803) | 2.44082604 |
| 44 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41678562 |
| 45 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41678562 |
| 46 | Pancytopenia (HP:0001876) | 2.40466967 |
| 47 | Granulocytopenia (HP:0001913) | 2.39788798 |
| 48 | Increased hepatocellular lipid droplets (HP:0006565) | 2.36767210 |
| 49 | Lymphopenia (HP:0001888) | 2.35467645 |
| 50 | Pulmonary infiltrates (HP:0002113) | 2.35225962 |
| 51 | Autoimmune thrombocytopenia (HP:0001973) | 2.34176434 |
| 52 | Joint swelling (HP:0001386) | 2.32283925 |
| 53 | Hypoalbuminemia (HP:0003073) | 2.31614466 |
| 54 | Abnormal albumin level (HP:0012116) | 2.31614466 |
| 55 | Hemiplegia (HP:0002301) | 2.30513694 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29282484 |
| 57 | Obstructive lung disease (HP:0006536) | 2.29282484 |
| 58 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27400184 |
| 59 | Renal Fanconi syndrome (HP:0001994) | 2.25368648 |
| 60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.25345933 |
| 61 | Abnormality of T cell physiology (HP:0011840) | 2.23600419 |
| 62 | Vasculitis (HP:0002633) | 2.22533794 |
| 63 | Pustule (HP:0200039) | 2.22115084 |
| 64 | Lipid accumulation in hepatocytes (HP:0006561) | 2.21251836 |
| 65 | Increased muscle lipid content (HP:0009058) | 2.21148328 |
| 66 | Acute hepatic failure (HP:0006554) | 2.21053913 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.18464028 |
| 68 | Optic neuritis (HP:0100653) | 2.18464028 |
| 69 | Gangrene (HP:0100758) | 2.16562094 |
| 70 | Hypergammaglobulinemia (HP:0010702) | 2.16229932 |
| 71 | Stomach cancer (HP:0012126) | 2.14136516 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.11073189 |
| 73 | Recurrent fungal infections (HP:0002841) | 2.10329526 |
| 74 | Progressive macrocephaly (HP:0004481) | 2.10219895 |
| 75 | Pancreatic cysts (HP:0001737) | 2.09280344 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.06881015 |
| 77 | Orchitis (HP:0100796) | 2.05144930 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.04451341 |
| 79 | Methylmalonic aciduria (HP:0012120) | 2.02874365 |
| 80 | Mediastinal lymphadenopathy (HP:0100721) | 2.00870511 |
| 81 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.99673233 |
| 82 | Hemoptysis (HP:0002105) | 1.98137340 |
| 83 | Agammaglobulinemia (HP:0004432) | 1.97581183 |
| 84 | Chest pain (HP:0100749) | 1.94574436 |
| 85 | Acute encephalopathy (HP:0006846) | 1.93309344 |
| 86 | Abolished electroretinogram (ERG) (HP:0000550) | 1.92599753 |
| 87 | Abnormality of the renal cortex (HP:0011035) | 1.91735203 |
| 88 | Gastrointestinal infarctions (HP:0005244) | 1.91362156 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 1.91346615 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.91346615 |
| 91 | Abnormality of midbrain morphology (HP:0002418) | 1.89121427 |
| 92 | Molar tooth sign on MRI (HP:0002419) | 1.89121427 |
| 93 | Recurrent viral infections (HP:0004429) | 1.87774674 |
| 94 | Ureteral stenosis (HP:0000071) | 1.86600793 |
| 95 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.86046142 |
| 96 | Increased serum lactate (HP:0002151) | 1.85579580 |
| 97 | Severe visual impairment (HP:0001141) | 1.84065669 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 1.82975300 |
| 99 | Lymphoma (HP:0002665) | 1.82556898 |
| 100 | Decreased central vision (HP:0007663) | 1.81884362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 6.35187454 |
| 2 | TXK | 6.14938736 |
| 3 | TESK2 | 5.27803810 |
| 4 | MAP4K1 | 2.81333139 |
| 5 | BCKDK | 2.71634622 |
| 6 | ITK | 2.32411030 |
| 7 | TAOK3 | 2.22284282 |
| 8 | TESK1 | 2.14891912 |
| 9 | TLK1 | 2.06927224 |
| 10 | ZAK | 1.90758489 |
| 11 | LIMK1 | 1.86767037 |
| 12 | ADRBK2 | 1.83355080 |
| 13 | VRK2 | 1.83162552 |
| 14 | SYK | 1.72286777 |
| 15 | WNK4 | 1.58715318 |
| 16 | GRK6 | 1.56477658 |
| 17 | FES | 1.56177468 |
| 18 | MAP3K12 | 1.51478501 |
| 19 | SCYL2 | 1.51439159 |
| 20 | GRK1 | 1.48679924 |
| 21 | GRK7 | 1.48166727 |
| 22 | PRKCQ | 1.46311148 |
| 23 | LCK | 1.45098876 |
| 24 | CSF1R | 1.38636555 |
| 25 | CSK | 1.37415435 |
| 26 | MAP4K2 | 1.36216465 |
| 27 | TEC | 1.34751586 |
| 28 | KIT | 1.33510084 |
| 29 | ZAP70 | 1.31283763 |
| 30 | MST4 | 1.22725324 |
| 31 | BTK | 1.22396976 |
| 32 | IKBKB | 1.20775810 |
| 33 | IKBKE | 1.14925111 |
| 34 | TBK1 | 1.13335974 |
| 35 | PASK | 1.05765911 |
| 36 | LYN | 1.04770589 |
| 37 | NUAK1 | 1.02048158 |
| 38 | MAP2K6 | 0.99578043 |
| 39 | MAPKAPK3 | 0.98833940 |
| 40 | MAP2K2 | 0.98378524 |
| 41 | MUSK | 0.98235724 |
| 42 | MAP3K11 | 0.94430211 |
| 43 | JAK3 | 0.93844173 |
| 44 | FRK | 0.93456439 |
| 45 | PINK1 | 0.93437538 |
| 46 | MAP3K14 | 0.90787856 |
| 47 | FLT3 | 0.90356188 |
| 48 | VRK1 | 0.88220986 |
| 49 | INSRR | 0.83247970 |
| 50 | STK16 | 0.80759608 |
| 51 | PIK3CG | 0.80715863 |
| 52 | PIK3CA | 0.80294721 |
| 53 | TIE1 | 0.76597278 |
| 54 | MYLK | 0.75482712 |
| 55 | CAMKK2 | 0.72975984 |
| 56 | BUB1 | 0.71180434 |
| 57 | BLK | 0.61822549 |
| 58 | FYN | 0.59938847 |
| 59 | PIM1 | 0.59605717 |
| 60 | RPS6KA5 | 0.58635600 |
| 61 | OBSCN | 0.58558850 |
| 62 | IGF1R | 0.57145723 |
| 63 | DAPK1 | 0.56422963 |
| 64 | ROCK1 | 0.54376694 |
| 65 | OXSR1 | 0.53795517 |
| 66 | TRPM7 | 0.52958160 |
| 67 | ADRBK1 | 0.47907281 |
| 68 | HCK | 0.44335135 |
| 69 | CAMKK1 | 0.42944730 |
| 70 | INSR | 0.42460747 |
| 71 | NME1 | 0.41060977 |
| 72 | STK39 | 0.41040988 |
| 73 | MATK | 0.40648432 |
| 74 | PRKCA | 0.40258500 |
| 75 | STK10 | 0.38723492 |
| 76 | AURKA | 0.37402115 |
| 77 | RIPK4 | 0.36878557 |
| 78 | DAPK2 | 0.33632242 |
| 79 | GRK5 | 0.32798899 |
| 80 | WNK3 | 0.32386847 |
| 81 | TGFBR2 | 0.30592670 |
| 82 | PIM2 | 0.30583262 |
| 83 | RPS6KA4 | 0.30259398 |
| 84 | TNK2 | 0.29716903 |
| 85 | ABL1 | 0.29679661 |
| 86 | PRKACA | 0.29486266 |
| 87 | JAK2 | 0.26887304 |
| 88 | BMPR2 | 0.26833505 |
| 89 | ERBB3 | 0.26086204 |
| 90 | EGFR | 0.23267255 |
| 91 | CDK8 | 0.21555558 |
| 92 | PHKG1 | 0.21480597 |
| 93 | PHKG2 | 0.21480597 |
| 94 | ATR | 0.21091323 |
| 95 | CSNK2A1 | 0.19940219 |
| 96 | PAK1 | 0.19128490 |
| 97 | CAMK2A | 0.18500567 |
| 98 | MAPK3 | 0.18401660 |
| 99 | IRAK4 | 0.17776526 |
| 100 | MAPK13 | 0.17360844 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.45580364 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.61346317 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.55377389 |
| 4 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.32020117 |
| 5 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.28088503 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.13798470 |
| 7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.92918991 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.76367827 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.72950303 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.66678303 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.46401798 |
| 12 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.45283177 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.32043795 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.11315737 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.03311714 |
| 16 | Asthma_Homo sapiens_hsa05310 | 1.87881995 |
| 17 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.73779592 |
| 18 | Protein export_Homo sapiens_hsa03060 | 1.54951431 |
| 19 | Alzheimers disease_Homo sapiens_hsa05010 | 1.52387115 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.50117220 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.47928272 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46414530 |
| 23 | Phototransduction_Homo sapiens_hsa04744 | 1.43341748 |
| 24 | RNA polymerase_Homo sapiens_hsa03020 | 1.42833171 |
| 25 | Ribosome_Homo sapiens_hsa03010 | 1.41652043 |
| 26 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.36341156 |
| 27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34291477 |
| 28 | Measles_Homo sapiens_hsa05162 | 1.31250470 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.30251090 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28377263 |
| 31 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.26020588 |
| 32 | Shigellosis_Homo sapiens_hsa05131 | 1.21215601 |
| 33 | Huntingtons disease_Homo sapiens_hsa05016 | 1.18492364 |
| 34 | Salmonella infection_Homo sapiens_hsa05132 | 1.16578222 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.05225719 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.03832465 |
| 37 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.03450468 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01896427 |
| 39 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01052597 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89787924 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.88579991 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 0.85951975 |
| 43 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85084839 |
| 44 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84451369 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82382350 |
| 46 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.80799925 |
| 47 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77282120 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72651733 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71123634 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.70294714 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.66132634 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.63556768 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63079891 |
| 54 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57662200 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.54804937 |
| 56 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.53092567 |
| 57 | Legionellosis_Homo sapiens_hsa05134 | 0.52487896 |
| 58 | Homologous recombination_Homo sapiens_hsa03440 | 0.51779165 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49949944 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.48418636 |
| 61 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48039459 |
| 62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.47740576 |
| 63 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47136550 |
| 64 | Purine metabolism_Homo sapiens_hsa00230 | 0.46583559 |
| 65 | Olfactory transduction_Homo sapiens_hsa04740 | 0.46341146 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46082925 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.45370230 |
| 68 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45339340 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.43457932 |
| 70 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41943486 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.39702044 |
| 72 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.39692360 |
| 73 | Retinol metabolism_Homo sapiens_hsa00830 | 0.36843151 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35975684 |
| 75 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.35368832 |
| 76 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34605440 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31881927 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.31784108 |
| 79 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.29997694 |
| 80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.29985079 |
| 81 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28781977 |
| 82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26604371 |
| 83 | Morphine addiction_Homo sapiens_hsa05032 | 0.23641858 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.23317563 |
| 85 | Apoptosis_Homo sapiens_hsa04210 | 0.23306452 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.22888380 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22797950 |
| 88 | Nicotine addiction_Homo sapiens_hsa05033 | 0.21509600 |
| 89 | Tuberculosis_Homo sapiens_hsa05152 | 0.21362195 |
| 90 | Influenza A_Homo sapiens_hsa05164 | 0.20893909 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19530513 |
| 92 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.17812553 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16800508 |
| 94 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16667103 |
| 95 | Taste transduction_Homo sapiens_hsa04742 | 0.15988500 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.14329794 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.13616800 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.13349967 |
| 99 | Basal transcription factors_Homo sapiens_hsa03022 | 0.13301585 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12500102 |

